Wilmington, DE, United States of America

Mark John Brown, Jr

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark John Brown, Jr. - Innovator in Biopharmaceutical Flow Technology

Introduction

Mark John Brown, Jr. is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of biopharmaceutical technology, particularly in fluid flow control systems. His innovative work has led to the development of a patented technology that enhances the efficiency and safety of biopharmaceutical liquid container assemblies.

Latest Patents

Mark holds a patent for a biopharmaceutical flow port, which includes a hose barb coupled to an elliptic body. This invention describes a method for manufacturing the biopharmaceutical flow port and the biopharmaceutical liquid container assembly. The flow port features a bore within the hose barb and a flow passage in the elliptic body, which is fluidly coupled to the bore. The design includes a first edge and a second edge extending from the elliptic body in opposite directions, optimizing fluid flow management. This patent is a testament to his innovative approach in the biopharmaceutical sector, with a total of 1 patent to his name.

Career Highlights

Mark is currently employed at Ilc Dover, Inc., where he continues to develop cutting-edge technologies in the biopharmaceutical industry. His work focuses on improving the design and functionality of liquid container assemblies, which are crucial for the safe handling of biopharmaceutical products.

Collaborations

Throughout his career, Mark has collaborated with talented professionals such as Hayden Lloyd and Kraig Ford. These partnerships have fostered a creative environment that encourages innovation and the development of new technologies in the field.

Conclusion

Mark John Brown, Jr. is a dedicated inventor whose work in biopharmaceutical flow technology has made a significant impact on the industry. His patented innovations demonstrate his commitment to enhancing the safety and efficiency of biopharmaceutical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…